ArticleScientific reports2025
First HPLC-UV method for the determination of homocysteine thiolactone in human urine after derivatization with 1-benzyl-2-chloropyridinium bromide.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quantum-Dot-Based Molecularly Imprinted Hydrogel for Rapid Detection of Homocysteine.Gels (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The report presents first high performance liquid chromatography coupled with ultraviolet detection (HPLC-UV) based method for the determination of homocysteine thiolactone (HTL) in human urine. Sample preparation procedure chiefly involves chloroform liquid-liquid extraction of HTL and its re-extraction with hydrochloric acid, followed by evaporation to dryness and treatment of the residue with 1-benzyl-2-chloropyridinium bromide and perchloric acid. The chromatographic separation of obtained UV-absorbing 2-S-pyridinium derivative is achieved within 6 min at 25 °C on Zorbax SB-C18 (150 × 4.6 mm, 5 μm) column using gradient elution. The eluent consists of 0.1% acetic acid in a mixture with acetonitrile delivered at a flow rate of 1 mL/min. The analyte is quantified by monitoring at 316 nm. The assay linearity was observed within 0.1-1.0 µmol/L in urine. The limit of quantification was found to be 100 nmol/L. The accuracy ranged from 92.56 to 112.51% and 92.56-114.31%, while precision varied from 5.89 to 11.27% and 3.85-14.25% for intra- and inter-assay measurements, respectively. The method was successfully applied to urine samples delivered by apparently healthy donors. The presence of HTL was confirmed in twelve of eighteen study samples. The HTL concentration ranged from 36.67 to 693.12 nmol/L.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.